Grant: VALLEY FEVER SOLUTIONS, INC.
Primary Recipient
VALLEY FEVER SOLUTIONS, INC.
Amount
$2,999,834.00
Award Date
5/08/2010
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
'Nikkomycin Z treatment of early coccidioidal pneumonia: Phase II clinical trial.' This project will further the development of a new, potentially curative drug, nikkomycin Z, to treat the fungal infection, Valley Fever (coccidioidomycosis).
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
VALLEY FEVER SOLUTIONS, INC. | Primary recipient | $1,697,468.00 |
REGENTS OF THE UNIVERSITY OF MINNESOTA | Sub-recipient | $1,302,366.00 |
Vendors Connected to Award
Vendor | Role | Amount |
---|---|---|
Florida Biologix | Primary vendor | $50,000.00 |
Biologics Process Development, Inc. | Sub-vendor | $25,892.50 |